Cancer Incidence among Females for Livingston County, 1976-2008
Source: New York State Cancer Registry
| Site of Cancer | 1976-1981 | 1982-1987 | 1988-1993 | 1994-1998 | 1999-2003 | 2004-2008 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | Ave. Cases | Adj Rate | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 94.7 | 363.4 | 30.4 | 116.8 | 424.0 | 32.0 | 131.0 | 431.1 | 30.5 | 142.4 | 451.9 | 33.4 | 152.8 | 468.4 | 33.4 | 168.0 | 487.2 | 33.9 |
| Oral cavity and pharynx | 1.5 | 5.7 | 3.8 | 1.8 | 6.4 | 3.9 | 0.7 | 2.5 | 2.5 | 2.0 | 6.4 | 4.0 | 2.4 | 7.4 | 4.2 | 3.8 | 11.5 | 5.3 |
| Esophagus | 0.2 | 0.6 | 1.2 | 0.3 | 1.1 | 1.5 | 0.3 | 1.0 | 1.4 | 0.6 | 2.0 | 2.2 | 0.4 | 1.3 | 1.8 | 1.0 | 3.0 | 2.7 |
| Stomach | 1.3 | 5.0 | 3.5 | 0.7 | 2.1 | 2.1 | 1.7 | 5.5 | 3.5 | 1.0 | 3.1 | 2.8 | 2.2 | 6.8 | 4.0 | 1.2 | 3.3 | 2.7 |
| Colorectal | 17.7 | 68.3 | 13.2 | 18.8 | 66.1 | 12.3 | 19.5 | 60.9 | 11.1 | 19.0 | 58.2 | 11.8 | 20.0 | 58.7 | 11.6 | 19.2 | 53.1 | 11.0 |
| Colon excluding rectum | 11.2 | 43.3 | 10.5 | 14.7 | 51.5 | 10.9 | 14.8 | 46.9 | 9.8 | 14.2 | 43.4 | 10.2 | 16.4 | 47.8 | 10.4 | 13.8 | 37.9 | 9.3 |
| Rectum & rectosigmoid | 6.5 | 25.0 | 7.9 | 4.2 | 14.6 | 5.8 | 4.7 | 14.0 | 5.2 | 4.8 | 14.8 | 6.0 | 3.6 | 11.0 | 5.1 | 5.4 | 15.2 | 5.9 |
| Liver / intrahepatic bile duct | 0.5 | 1.6 | 1.9 | 0.3 | 1.4 | 2.0 | 0.3 | 1.1 | 1.5 | 1.0 | 3.0 | 2.7 | 0.4 | 1.4 | 2.0 | 2.0 | 6.0 | 3.7 |
| Pancreas | 2.7 | 9.4 | 4.6 | 3.5 | 12.3 | 5.3 | 4.5 | 14.7 | 5.6 | 2.8 | 8.5 | 4.5 | 3.2 | 9.7 | 4.8 | 3.2 | 8.4 | 4.1 |
| Larynx | 0.7 | 2.5 | 2.5 | 0.7 | 2.6 | 2.6 | 0.5 | 1.8 | 2.1 | 0.2 | 0.6 | 1.2 | 1.0 | 3.2 | 2.8 | 0.2 | 0.5 | 1.0 |
| Lung and bronchus | 8.7 | 32.9 | 9.1 | 14.2 | 52.8 | 11.5 | 14.5 | 48.9 | 10.4 | 16.8 | 54.9 | 11.8 | 18.8 | 58.3 | 11.8 | 23.8 | 66.2 | 12.0 |
| Melanoma of the skin | 1.5 | 6.1 | 4.1 | 2.0 | 6.7 | 3.8 | 1.8 | 5.7 | 3.4 | 2.4 | 8.0 | 4.5 | 3.2 | 10.2 | 5.1 | 3.4 | 11.8 | 5.8 |
| Female breast | 24.5 | 95.9 | 15.8 | 32.7 | 125.5 | 18.0 | 39.3 | 133.8 | 17.3 | 44.0 | 142.9 | 19.0 | 43.8 | 136.2 | 18.1 | 50.4 | 142.8 | 17.8 |
| Cervix uteri | 2.8 | 11.4 | 5.5 | 1.8 | 6.3 | 3.8 | 3.5 | 11.2 | 4.9 | 2.4 | 7.6 | 4.3 | 1.8 | 5.7 | 3.8 | 2.6 | 9.3 | 5.6 |
| Corpus uterus and NOS | 7.7 | 29.2 | 8.6 | 10.2 | 35.9 | 9.2 | 8.2 | 27.4 | 7.7 | 11.4 | 37.6 | 9.8 | 10.0 | 31.1 | 8.6 | 9.4 | 28.0 | 8.4 |
| Ovary | 3.5 | 14.0 | 6.1 | 4.0 | 14.9 | 6.1 | 4.7 | 15.7 | 5.9 | 4.0 | 12.7 | 5.6 | 6.6 | 20.0 | 6.8 | 6.4 | 18.3 | 6.4 |
| Urinary bladder (incl. in situ) | 3.2 | 12.4 | 5.6 | 3.0 | 10.7 | 5.0 | 2.8 | 8.4 | 4.0 | 4.0 | 12.2 | 5.4 | 4.2 | 12.6 | 5.4 | 5.6 | 16.5 | 6.2 |
| Kidney and renal pelvis | 1.8 | 7.5 | 4.5 | 1.0 | 3.1 | 2.5 | 2.0 | 6.4 | 3.6 | 2.0 | 6.4 | 4.0 | 4.6 | 13.7 | 5.6 | 4.8 | 15.5 | 6.7 |
| Brain and other nervous system | 1.2 | 4.4 | 3.4 | 2.2 | 7.6 | 4.2 | 2.0 | 6.4 | 3.6 | 2.0 | 6.2 | 3.9 | 2.6 | 8.1 | 4.4 | 1.4 | 4.2 | 3.3 |
| Thyroid | 1.3 | 4.5 | 3.2 | 1.8 | 5.8 | 3.6 | 2.8 | 8.9 | 4.3 | 1.4 | 4.2 | 3.2 | 3.6 | 11.0 | 5.1 | 3.8 | 13.8 | 6.7 |
| Hodgkin lymphoma | 1.0 | 3.2 | 2.7 | 0.7 | 1.9 | 2.1 | 1.3 | 3.8 | 2.7 | 1.0 | 3.1 | 2.8 | 0.8 | 2.7 | 2.7 | 0.2 | 0.4 | 0.7 |
| Non-Hodgkin lymphomas | 3.8 | 14.4 | 6.0 | 3.3 | 11.5 | 5.1 | 5.7 | 19.5 | 6.6 | 5.8 | 17.3 | 6.3 | 6.8 | 20.5 | 6.9 | 5.2 | 14.8 | 5.7 |
| Multiple myeloma | 0.7 | 2.6 | 2.5 | 1.3 | 5.0 | 3.5 | 1.0 | 3.0 | 2.4 | 1.8 | 5.5 | 3.6 | 0.4 | 1.1 | 1.6 | 2.6 | 7.3 | 4.0 |
| Leukemias | 3.3 | 12.1 | 5.4 | 3.2 | 11.0 | 5.0 | 4.0 | 13.1 | 5.3 | 3.2 | 10.1 | 5.0 | 5.4 | 16.9 | 6.5 | 5.8 | 17.6 | 6.9 |
Notes:
- Incidence data are provisional, November 2010.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- The data in this table are not identical to the data in the corresponding 2004-2008 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
